Related Experiment Video
Updated: Aug 14, 2026

An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
Are vanadium compounds drugable? Structures and effects of antidiabetic vanadium compounds: a critical review
Thomas Scior1, Antonio Guevara-García, Philippe Bernard
1Departamento de Farmacia, Facultad de Ciencias Químicas, Universidad Autónoma de Puebla, Av. 14 Sur y Av. San Claudio, Col, San Manuel, Puebla, Pue, México. tscior@siu.buap.mx
Abstract:
Vanadate can be bioequivalent to phosphate and replace it in cellular metabolism. The detection of insulin-like activity has spurred interest in the development of oral anti-diabetic drugs containing vanadium. We collected and evaluated a vast toxicity data set and discussed molecular aspects related to insulin-mimetic effects of vanadium complexes.
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: Glinides
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are typically...
